Company Overview and News

3
Teck Resources (TECK) Q3 Earnings Preview: What to Know Ahead of the Release

2018-10-18 zacks
The market expects Teck Resources (TECK - Free Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2018. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
WYNN TCKRF TECK

5
Lithium Is Yesterday’s News – Vanadium Is The Future

2018-10-17 oilprice
Your license and viewing of our content is subject to the disclosures contained after this article.
PVG MGA NEM MG FTI.WI FMC PVG UBMCF DSGX TCKRF TECK

108
WCS And Edmonton Mixed Sweet Discounts To WTI: Darkest Before Dawn

2018-10-16 seekingalpha - 2
Activism in Canada is largely responsible for transportation constraints such as pipeline bottlenecks, hurting the Canadian economy in ways that Canadians could never imagine.
BTE CVE CRLFF CEI TOT ENB IMO CNI ZPTAF CHAP RRENF SNZYP TDG SN TRP IMO MEG HKRCP BP VET CVE BTE ECR USEG CHPE CP USO IKM CJ GST-A GST-B GST PTOAF WCP SCAZP HUSKF AXAS PTOAD SGY VET SPE TECK HSE AREX TDGCF CP ROSEU REI AMR MEGEF IPCFF TCKRF RRX ROSE PDS PRCYF RZREF HK SPGYF PTORF

1
TECK / Teck Resources Ltd. EXHIBIT 6-K (Current Report of Foreign Issuer)

2018-10-05 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TECK

1
Teck Receives Regulatory Approval for Share Buy-Back Program

2018-10-04 globenewswire
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) has been informed that the Toronto Stock Exchange (“TSX”) has accepted Teck’s notice of intention to make a normal course issuer bid to purchase its Class B subordinate voting shares (“Class B Shares”).
DTK TCKRF TECK

1
Eco-group tells hearing Frontier oilsands megaproject would be a 'carbon disaster'

2018-10-04 cbc.ca
Some environmental groups are warning Teck Resources's proposed Frontier oilsands mine will be a "carbon disaster" with direct emissions comparable to adding almost 900,000 vehicles on the road.
TCKRF TECK

3
TECK / Teck Resources Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-09-27 sec.gov - 2
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TECK

4
TECK / Teck Resources Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-09-26 sec.gov - 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TECK

1
Montem Resources raising $20 million to develop metallurgical coal mines in Canada

2018-09-26 proactiveinvestors.com.au
Montem Resources Ltd (ASX:MR1) has lodged its prospectus to raise up to $20 million and list on the ASX via an initial public offering (IPO).
TCKRF TECK

1
UNICEF Canada and Teck partner to save the lives of children in India

2018-09-25 globenewswire
NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- UNICEF Canada and Teck Resources Limited (Teck) today announced that Teck has committed to invest an additional CAD$2.5 million to support life-saving zinc and oral rehydration salt (ORS) treatments for children in India over the next five years. This investment builds upon the CAD$5 million that Teck committed to UNICEF in 2013. Over the past five years, the partnership has saved the lives of 62,000 children in India.
DTK TCKRF TECK

2
TECK / Teck Resources Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-09-19 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TECK

1
Teck Media and Investor Webcast Advisory

2018-09-18 globenewswire
VANCOUVER, British Columbia, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) Senior Vice President, Finance and Chief Financial Officer, Ron Millos will be presenting at the Deutsche Bank 26th Annual Leveraged Finance Conference on Tuesday, October 2, 2018 at 4:35 p.m. Eastern/1:35 p.m. Pacific time. The investor presentation will include information on company strategy, financial performance, and outlook for the company’s business units.
DB DTK TCKRF TECK

4
TECK / Teck Resources Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-09-17 sec.gov - 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TECK

1
Best Drill Interceptions In The Metals Mining Sector For The Week Ended 9 September 2018

2018-09-14 seekingalpha
Welcome to the fourth edition of Gold Panda's weekly series of articles covering the best drill interception in the metals mining sector. My first three articles from the series can be read here, here and here.
WLBMF AZZVF AVZ TECK

1
Teck Named to 2018 Dow Jones Sustainability World Index

2018-09-14 globenewswire
VANCOUVER, British Columbia, Sept. 14, 2018 (GLOBE NEWSWIRE) -- For the ninth straight year, Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) has been named to the Dow Jones Sustainability World Index (DJSI), indicating that Teck’s sustainability practices are in the top 10 percent of the 2,500 largest companies in the S&P Global Broad Market Index (BMI).
DTK TCKRF TECK

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TECK / Teck Resources Ltd. on message board site Silicon Investor.

Vanteck (vrb-cdnx, vttcf) Vanteck (vrb-cdnx, vttcf) Vanteck (vrb-cdnx, vttcf) Teck Corporation TEK.A TEK.B Canadian u0026#034;ehu0026#034; Teck Corporation TEK.A TEK.B Canadian u0026#034;ehu0026#034; Teck Corporation TEK.A TEK.B Canadian u0026#034;ehu0026#034;
SIV /vse- STARTECK INDUSTRIES LTD SIV /vse- STARTECK INDUSTRIES LTD SIV /vse- STARTECK INDUSTRIES LTD ORBK: Orboteck Ltd (formerly ORBKF) ORBK: Orboteck Ltd (formerly ORBKF) ORBK: Orboteck Ltd (formerly ORBKF)
Brighton Teck (BGHT) Brighton Teck (BGHT) Brighton Teck (BGHT)
CUSIP: 878742204